Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher Leveque

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Journal of Clinical Apheresis|September 28, 2010
Therapeutic plasma exchange a potential strategy for patients with advanced heart failureGuillermo Torre-Amione, Carlos M Orrego, Nashwa Khalil, et al.
Molecular Cancer Therapeutics|July 24, 2014
BET protein antagonist JQ1 is synergistically lethal with FLT3 tyrosine kinase inhibitor (TKI) and overcomes resistance to FLT3-TKI in AML cells expressing FLT-ITDWarren Fiskus, Sunil Sharma, Jun Qi, et al.
Journal of Clinical Apheresis|August 4, 2021
Ultrasound-based criteria for adequate peripheral venous access in therapeutic apheresis proceduresEric Salazar, Faaria Gowani, Francisco Segura, et al.
World Neurosurgery|February 4, 2024
Randomized Trial of Augmented Pelvic Fixation in Patients Undergoing Thoracolumbar Fusion for Adult Spine Deformity: Initial Results from a Multicenter Randomized TrialDavid Polly, Greg Mundis, Robert Eastlack, et al.
The American Journal of Pathology|August 16, 2020
Treatment of Coronavirus Disease 2019 Patients with Convalescent Plasma Reveals a Signal of Significantly Decreased MortalityEric Salazar, Paul A Christensen, Edward A Graviss, et al.
The American Journal of Pathology|November 6, 2020
Significantly Decreased Mortality in a Large Cohort of Coronavirus Disease 2019 (COVID-19) Patients Transfused Early with Convalescent Plasma Containing High-Titer Anti-Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Spike Protein IgGEric Salazar, Paul A Christensen, Edward A Graviss, et al.
Communications Biology|February 25, 2021
Limited window for donation of convalescent plasma with high live-virus neutralizing antibody titers for COVID-19 immunotherapyAbhinay Gontu, Sreenidhi Srinivasan, Eric Salazar, et al.
The Journal of Clinical Investigation|September 10, 2020
Convalescent plasma anti-SARS-CoV-2 spike protein ectodomain and receptor-binding domain IgG correlate with virus neutralizationEric Salazar, Suresh V Kuchipudi, Paul A Christensen, et al.
Medrxiv : the Preprint Server for Health Sciences|June 9, 2020
Treatment of COVID-19 Patients with Convalescent Plasma in Houston, TexasEric Salazar, Katherine K Perez, Madiha Ashraf, et al.
The American Journal of Pathology|May 31, 2020
Treatment of Coronavirus Disease 2019 (COVID-19) Patients with Convalescent PlasmaEric Salazar, Katherine K Perez, Madiha Ashraf, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Journal of Clinical Apheresis|September 28, 2010
Therapeutic plasma exchange a potential strategy for patients with advanced heart failureGuillermo Torre-Amione, Carlos M Orrego, Nashwa Khalil, et al.
Molecular Cancer Therapeutics|July 24, 2014
BET protein antagonist JQ1 is synergistically lethal with FLT3 tyrosine kinase inhibitor (TKI) and overcomes resistance to FLT3-TKI in AML cells expressing FLT-ITDWarren Fiskus, Sunil Sharma, Jun Qi, et al.
Journal of Clinical Apheresis|August 4, 2021
Ultrasound-based criteria for adequate peripheral venous access in therapeutic apheresis proceduresEric Salazar, Faaria Gowani, Francisco Segura, et al.
World Neurosurgery|February 4, 2024
Randomized Trial of Augmented Pelvic Fixation in Patients Undergoing Thoracolumbar Fusion for Adult Spine Deformity: Initial Results from a Multicenter Randomized TrialDavid Polly, Greg Mundis, Robert Eastlack, et al.
The American Journal of Pathology|August 16, 2020
Treatment of Coronavirus Disease 2019 Patients with Convalescent Plasma Reveals a Signal of Significantly Decreased MortalityEric Salazar, Paul A Christensen, Edward A Graviss, et al.
The American Journal of Pathology|November 6, 2020
Significantly Decreased Mortality in a Large Cohort of Coronavirus Disease 2019 (COVID-19) Patients Transfused Early with Convalescent Plasma Containing High-Titer Anti-Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Spike Protein IgGEric Salazar, Paul A Christensen, Edward A Graviss, et al.
Communications Biology|February 25, 2021
Limited window for donation of convalescent plasma with high live-virus neutralizing antibody titers for COVID-19 immunotherapyAbhinay Gontu, Sreenidhi Srinivasan, Eric Salazar, et al.
The Journal of Clinical Investigation|September 10, 2020
Convalescent plasma anti-SARS-CoV-2 spike protein ectodomain and receptor-binding domain IgG correlate with virus neutralizationEric Salazar, Suresh V Kuchipudi, Paul A Christensen, et al.
Medrxiv : the Preprint Server for Health Sciences|June 9, 2020
Treatment of COVID-19 Patients with Convalescent Plasma in Houston, TexasEric Salazar, Katherine K Perez, Madiha Ashraf, et al.
The American Journal of Pathology|May 31, 2020
Treatment of Coronavirus Disease 2019 (COVID-19) Patients with Convalescent PlasmaEric Salazar, Katherine K Perez, Madiha Ashraf, et al.
Pageof 3